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Abstract. This data-driven computational psychiatry research  proposes a novel 
machine learning approach to developing predictive models for the onset of first-
episode psychosis, based on artificial neural networks. The performance 
capabilities of the predictive models are enhanced and evaluated by a 
methodology consisting of novel model optimisation and testing, which 
integrates a phase of model tuning, a phase of model post-processing with ROC 
optimisation based on maximum accuracy, Youden and top-left methods, and a 
model evaluation with the k-fold cross-testing methodology. We further extended 
our framework by investigating the cannabis use attributes’ predictive power, and 
demonstrating statistically that their presence in the dataset enhances the 
prediction performance of the neural network models. Finally, the model stability 
is explored via simulations with 1000 repetitions of the model building and 
evaluation experiments. The results show that our best Neural Network model’s 
average accuracy of predicting first-episode psychosis, which is evaluated with 
Monte Carlo, is above 80%.  
Keywords: Machine Learning, Neural Networks, Prediction modelling, ROC 
optimisation, Monte Carlo, Computational Psychiatry, Cannabis, Psychosis 
1 Introduction 
Policy changes and the legalisation of cannabis across countries, especially the Nether-
lands, Uruguay and some states in the USA, indicate that cannabis is gaining greater 
global acceptance. It has been reported that cannabis has been the most popular illicit 
drug in the world in the last decade, with an estimated 183 million annual users [1]. 
However, studies show that countries with higher cannabis consumption also have 
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higher proportions of people seeking treatment for psychotic disorders, including first-
episode psychosis, schizophrenia, anxiety and substance use disorders [2]. This makes 
it imperative to understand the likely consequences of cannabis use, even if these con-
sequences affect only a minority of users. Therefore, the link between cannabis con-
sumption and the risk of experiencing psychotic disorders must be thoroughly 
scrutinised.    
Recent researches have attempted to understand whether specific patterns of canna-
bis use, such as potency or age, are associated with a higher risk of developing psychotic 
disorders. One study concluded that nearly a quarter of all new psychosis patients in 
South London (UK) could be associated with the use of high-potency, skunk-like can-
nabis [3]. Another study [4] estimated that a person who uses cannabis daily for more 
than six months has a 70% likelihood of suffering from psychotic disorders. 
Few studies have used risk prediction modelling or advanced machine learning al-
gorithms to establish a link between cannabis use and first-episode psychosis. In fact, 
apart from our recent work [4], we are not aware of the existence of any such studies. 
Most prior studies have relied solely on explanatory research strategies and been based 
on various conventional statistical techniques, such as hypothesis formulation and ver-
ification via statistical tests, logistic regression modelling, etc. These methods are well-
recognised and widely used in medical research, but they rarely match the high potential 
of machine learning methods. The domain of machine learning has continued to de-
velop for many years, and advanced predictive techniques have been expanded and 
improved constantly. These advanced predictive techniques, in turn, are prompting ex-
tensive usage of computers and artificial intelligence techniques in many domains, such 
as medicine [5] [6]. Artificial neural networks have proven their remarkable ability to 
detect predictive patterns in different types of datasets of various complexities, and of-
ten showed their superiority compared with other machine learning techniques. 
Artificial neural networks are computational models that simulate the way biological 
neural networks process information in the human brain [7]. They are usually composed 
of several highly interconnected groups of artificial neurons that work together to solve 
specific problems. These computational models are typically used to model complex 
relationships between inputs and outputs, such as those in prediction models. Just like 
learning in biological neural networks, artificial neural networks process information 
by ‘tuning’ existing connections among neurons in order to process information. 
While techniques involving support vector machines are still popular within the ma-
chine learning community [4] [8], artificial neural networks are gaining considerable 
attention again. Recently, artificial neural networks have been successfully used in un-
derstanding the heterogeneous manifestations of asthma [9], diagnosing tuberculosis 
[10], classifying leukaemia [11], detecting heart conditions in electrocardiogram (ECG) 
data [12], etc. These studies show that neural networks are capable of handling complex 
medical data, such as ambiguous ECG signal data, and achieving outstanding results 
not yet produced by other methods. 
In this study, we offer a novel machine learning approach that uses neural networks 
to develop predictive models for the onset of first-episode psychosis. The dataset on 
which we based our study was collected by psychiatry practitioners and has been used 
in previously conducted studies, such as [3][4]. It comprises an extensive set of 
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variables, including demographic, drug-related and other variables, with specific 
information on participants' histories of cannabis use, as seen in Table 1.  
 
Table 1. Cannabis use attributes in the analysed dataset [4]. 
 
Attribute Description 
lifetime_cannabis_user Ever used cannabis: yes or no 
age_ﬁrst_cannabis Age upon the ﬁrst use of cannabis: 7 to 50 
age_ﬁrst_cannabis_under15 
 




Age less than 14 when ﬁrst used cannabis: yes, no or 
never used 
current_cannabis_user Current cannabis user: yes or no 
cannabis_fqcy 
 
Pattern of cannabis use: never used, only on weekends 




Cannabis usage measure: none, hash less than once per 
week, hash on weekends, hash daily, skunk less than 
once per week, skunk on weekends, skunk daily 
cannabis_type Cannabis type: never used, hash or skunk 
duration Cannabis use duration: 0 to 41 (months) 
 
Our paper proposes a novel data-driven computational psychiatry and machine 
learning approach to developing predictive models for the onset of first-episode 
psychosis, based on feed-forward artificial neural networks. The performance 
capabilities of the predictive models are enhanced and evaluated by a methodology 
consisting of model optimisation and testing, which integrates a phase of model tuning, 
a phase of model post-processing with ROC optimisation based on maximum accuracy, 
Youden and top-left methods, and a model evaluation with the k-fold cross-testing 
methodology. We further extend our framework by investigating the cannabis use 
attributes’ predictive power, and demonstrating statistically that their presence in the 
dataset enhances the prediction performance of the neural network models. Finally, the 
model stability is explored via simulations with 1000 repetitions of the model building 
and evaluation experiments. The results show that our best models’ accuracies in pre-
dicting first-episode psychosis in intensive Monte Carlo simulation fall between 
75.03% and 85.13%, with an average of about 81%.    
The rest of the paper is organised as follows. Section 2 presents our methodology 
for predicting the ﬁrst-episode psychosis, based on experimenting with artificial neural 
networks, and our novel methodology for model optimisation and post-processing, and 
evaluation with optimized cut-off point selection on the ROC curve. The section also 
investigates the outcomes of the extensive Monte Carlo simulations in order to study 
the variation of the models’ performance. In Section 3, we build optimised prediction 
models without the cannabis attributes to study if there is a statistically signiﬁcant 
difference with respect to the performances of the models using the cannabis attributes. 
Finally, the conclusion and the directions for future work are presented in Section 4. 
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2 Building Prediction models 
2.1 Data preparation   
The data we used to build our predictive models were a part of a case-control study 
[3]. The clinical data comprise 1106 records divided into 489 patients, 370 controls and 
247 unlabelled records. The patients were individuals who presented with first-episode 
psychosis to the inpatient units of the South London & Maudsley Mental Health Na-
tional Health Service (NHS) Foundation Trust. The controls were healthy people re-
cruited from the same area served by the Trust. The control samples were similar to the 
patient samples in age, gender, ethnicity, educational qualifications and employment 
status.  
Each record in the data refers to a participant in the study and has 255 possible 
attributes divided into four groups. The first group consists of demographic attributes, 
which represent general features like gender, race and level of education. The second 
group of drug-related attributes contains information on the use of non-cannabis drugs, 
such as tobacco, stimulants and alcohol. The third group contains genetic attributes. 
These were removed from the analysis for the purposes of this study. The final group 
contains cannabis-related attributes, such as the duration of use, initial date of use, fre-
quency, cannabis type, etc. (see Table 1). 
The goal of this stage is to perform a high-level simpliﬁcation of the dataset and to 
prepare the dataset for use in our novel approach to predict first-episode psychosis. This 
stage involved several steps. First, records that were missing critical data were removed 
from the dataset. This included both records with missing labels and records with miss-
ing values on all cannabis-related variables. Second, certain variables were removed 
from the dataset. This primarily included variables that were deemed to be irrelevant to 
the study (e.g. those related to the individual IDs of the study participants) and variables 
that fell outside the scope of the study (e.g. certain gene-related variables). In addition, 
any numeric predictors with zero or near-zero variance were dropped. Third, we sought 
to standardise the encoding of missing values across the dataset. Prior to this step, 
values including 66, 99 and -99 all represented cases with missing values; thus, we 
replaced all such indicators with a consistent missing value indicator: NA. Fourth, some 
variables were re-labelled to provide more intuitive descriptions of the data they con-
tained. In multiple situations, some variables had similar meanings but also records 
with missing values. Therefore, we conducted an imputation process to eﬀectively com-
bine the information from all the related variables into one. For example, two variables 
described alcohol use, but were inconsistently present and presented missing values 
across the records. These were combined in a way that created one single variable with 
consistent values that were as complete as possible. This process was used to generate 
value-reacher and value-consistent variables related to alcohol use, tobacco use, em-
ployment history and age.  
Finally, any attribute that had more than 50% missing values was removed from the 
study. We then dropped any record for which more than 70% of the remaining attributes 
contained missing values. The resulting dataset, after the transformations above, 
contained 783 records and 78 attributes. The records are divided into 451 patients and 
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332 controls. A summary of some of these ﬁelds—speciﬁcally, those that relate to can-
nabis use, such as type, the age of ﬁrst use and duration—can be seen in Table 1. 
2.2 Missing values treatment 
Although the data set was pre-processed and attributes with more than 50% missing 
values were removed, the final dataset still contained several missing values. Of the 
783 records, only 22.8% were complete cases. This volume of missing information 
makes modelling more challenging but is often the reality of medical and social re-
search. 
The predictive power of the data may depend signiﬁcantly on the way that missing 
values are treated. Some machine learning algorithms, such as decision trees [7], have 
the capability to handle missing data outright. However, most of machine learning al-
gorithms do not have the capability to handle missing data. In many situations, missing 
values are imputed using a supervised learning technique, such as k-Nearest Neighbour 
(KNN. These imputation techniques do not have theoretical formulations but are often 
applied in practice [4][6]. Several imputations techniques, such as the KNN imputation, 
the tree bagging imputation from the caret package [7] and the random forest imputa-
tion from the randomForest package [13] were considered in this work. The last 
method, although it was the most computationally expensive, produced the best results 
regarding the performance of the final predictive models.  
2.3 Training and tuning feed-forward artificial neural networks 
To develop optimised predictive models for first-episode psychosis, we controlled 
the values of the parameters for each of the considered algorithms using chosen grids. 
Predictive models have been fitted in a five-fold cross-validation procedure, on each 
training set after pre-processing techniques were applied on the same training set, and 
have been tested on each test set. Models based on single-layer and multi-hidden-layer 
neural networks were optimised (tuned) to maximise AUC, the area under the ROC 
curve.  
To avoid overfitting, the single-layer neural networks were tuned over 10 values for 
the size (i.e. the number of hidden units) and 10 values for the decay (i.e. the weight 
decay), which is the parameter in the penalisation method for model regularisation. This 
approach is like the penalisation method in ridge regression and is based on the L2 norm 
[7]. The optimal values were 17 and 0.01, respectively. Multi-layer neural networks 
were tuned over 10 values for each of the three hidden layers (i.e. 10 values for the 
number of hidden units in each layer) and over 10 values for the decay. The optimal 
values were 10, 10 and 10 for the three layers and 0.001 for the decay.  
2.4 Treating unbalanced classes  
When there is a priori knowledge of a class imbalance, one direct method to reduce the 
imbalance’s influence on model training is to select training set samples with roughly 
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equal event rates [7]. Treating data imbalances usually leads to better prediction models 
and a better trade-off between sensitivity and specificity.  
In this study, we considered three sampling approaches to sub-sample the training 
data in a manner that mitigated the imbalance problem. The first approach was down-
sampling, in which we sampled (without replacement) the majority class to be the same 
size as the minority class. The second method was up-sampling, in which we sampled 
(with replacement) the minority class to be the same size as the majority class. The last 
approach was the synthetic minority over-sampling technique (SMOTE) [14]. SMOTE 
selects a data point randomly from the minority class, determines the K nearest neigh-
bours to that point and then uses these neighbours to generate new synthetic data points 
using slight alterations. Our analysis used five neighbours. The results show that the 
up-sampling procedure yielded no real improvement in the AUC or the accuracy per-
formances. A simple down-sampling of the data also had no positive effect on the model 
performances. However, SMOTE with neural networks models led to an increase in 
both the AUC and the accuracy.  
As mentioned, data balancing supports a good trade-off between sensitivity and 
specificity. Another method that helps to balance sensitivity and specificity, or a good 
trade-off between the two performances, is model post-processing through the determi-
nation of new cut-off points on the ROC curves [7]. Our framework used three such 
methods, which can be seen as post-processing optimisations of the models. The first 
method found the point on the ROC curve closest to the top-left corner of the ROC plot, 
which represents the perfect model (100% sensitivity and 100% specificity). The sec-
ond method is Youden’s J index [15], which corresponds to the point on the ROC curve 
farthest from the main diagonal of the ROC plot. The third method, which is “maximum 
accuracy” found the cut-off, which is the point with the highest accuracy. 
In order to further improve the model performance, a specially designed post-pro-
cessing procedure and model evaluation were adapted in our modelling procedure. 
First, the dataset is stratified splatted randomly into in 60% training data and 40% eval-
uation data. Then, the training data is used for training and for optimising the model, as 
explained in Subsection 2.3, in a cross-validation fashion, with AUC as optimisation 
criterion, with and without class balancing. Different pre-processing methods such as 
missing values imputation and sampling methods that we have explained above were 
appropriately integrated into the cross-validation. The optimal model obtained on the 
training data was then applied to the evaluation dataset in a specially designed post-
processing procedure, which we call the k-fold cross-testing method.  
In the k-fold cross-testing method, we produce k post-processed model variants of 
the original optimised model. First, we create k stratified folds of the evaluation dataset. 
Then, k-1 folds are used to find an alternative probability cut-off on the ROC curve 
with one of the three specific methods presented above (top-left, Youden, and largest 
accuracy), obtaining a post-processed model variant. The remaining one-fold is scored 
with the post-processed model variant based on the newly found cut-off point. Finally, 
the whole procedure is repeated until all folds are used for scoring at their turn, then the 
predictions are integrated, and the model performance is measured on the whole  eval-
uation dataset. We note here as an essential remark that in each such iteration of the 
procedure, the ROC optimisation data (the k-1 folds) and the scored data (the remaining 
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fold) are always distinct, so the data for model post-processing and the data for scoring 
are always distinct.  
2.5 Increasing model performance via optimized cut-off point selection on the 
ROC curve 
The ROC curve is a graphical technique for evaluating the ability of a prediction model 
to discriminate between two classes, such as patients and controls. ROC curves allow 
visual analyses of the trade-offs between a predictive model’s sensitivity and specificity 
regarding various probability cut-offs. The curve is obtained by measuring the 
sensitivity and specificity of the predictive model at every cutting point and plotting the 
sensitivity against 1-specificity. The left image in Fig. 1 shows the ROC curves ob-
tained for both the single-layer neural networks and the multi-layer neural networks. 






Fig. 1. Left: The ROC curves for 2 of our optimised neural networks (NN) models: 
single-layer NN and multi-layer NN. 
Right: ROC optimisation post-processing of the multi-layer NN model, with 3 optimal 
cutting points: maximum accuracy, Youden and top-left methods. 
 
Numerous methods exist for finding a new cut-oﬀ. First, one can find the point on 
the ROC curve that is closest to the perfect model (100% sensitivity and 100% 
speciﬁcity), which is the point with shortest distance value from the point (0,1) as 
shown in the left image in Fig. 1. To find the shortest distance, [(1 - sensitivity)2 + (1 - 
specificity)2] was calculated and minimised [16]. Another approach for finding an op-
timal cut-off point on the ROC curve is finding the largest distance from the diagonal 
single-layer NN 
multi-layer NN 
Youden                          
top-left                           





to the ROC curve as shown in the right image in Fig. 1. This is the point with the largest 
value for the Youden index which is defined as (sensitivity + specificity -1) [15]. These 
are the two most popular methods for establishing the optimal cut-off [17] [7]. We used 
both of these methods, as well as the maximum accuracy approach, which determines 
the point on the ROC curve corresponding to the greatest accuracy (the red point in Fig. 
1, right). In our analysis, the optimal cutting point was derived from independent sets, 
rather than from the training set or the evaluation sets, as shown previously. This is 
particularly important, especially, for small datasets.  
2.6 Monte Carlo and models’ stability 
Due to the uncertainties introduced by the missing values in the data and due to 
expected variations of the predictive models' performance, depending on the datasets 
that were chosen for training and testing, we perform extensive Monte Carlo simula-
tions to study the performances’ variations and the models’ stability. The simulations 
for each NN consisted of 1,000 iterations of the proposed procedure. The models' per-
formances concerning accuracy, sensitivity, specificity and kappa were evaluated for 
each iteration on separate a testing dataset. The aggregation of all iterations yielded 
various distributions of the concerned performance measures. These distributions were 
then visualised using box plots in Fig. 2 to capture the models’ performance capability 
and stability. The subfigures in Fig. 2 were grouped by their performances’ measures 
into four subfigures. Each subfigure contained sex box plots for single-layer and multi-
layer neural networks with several optimized cut-off points on the ROC curve such as 
top-left, Youden index and the maximum accuracy. Also, estimations of the predictive 
neural networks’ performances regarding means and standard deviation (SD) are shown 
in Table 2. The results as shown in Table 2 are regarding the models’ performances 
when applied with the ROC optimisation techniques.  
 
Table 2. Estimations of the predictive neural networks’ performances. 
 
   Model 
Accuracy Kappa Sensitivity Specificity 
mean SD mean SD mean SD mean SD 
Single-layers NN (Youden) 0.76 0.03 0.52 0.05 0.76 0.05 0.75 0.05 
Single-layers NN (top-left) 0.76 0.02 0.52 0.05 0.77 0.04 0.76 0.04 
Single-layers NN (max accuracy) 0.79 0.02 0.56 0.05 0.83 0.04 0.73 0.05 
Multi-layers NN (Youden) 0.8 0.02 0.59 0.05 0.84 0.02 0.75 0.04 
Multi-layers NN (top-left) 0.81 0.02 0.61 0.04 0.84 0.02 0.76 0.03 
Multi-layers NN (max accuracy) 0.80 0.08 0.59 0.13 0.87 0.04 0.74 0.08 
 
On the one hand, single-layer neural networks with ROC optimisations based on 
Youden or top-left scored a mean accuracy of 0.76. The performance of the single-layer neural 
networks slightly improved when a ROC optimisation based on maximum accuracy was 
applied, resulting in a mean accuracy of 0.79 (95% CI [0.75, 0.83]) and a mean sensi-
tivity of 0.83 (95% CI [0.76, 0.9]). On the other hand, the multi-layer neural networks 
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with an ROC optimisation based on top-left cutting point achieved the best results with 
a mean accuracy of 0.81 (95% CI [0.77, 0.86]) and a mean sensitivity of 0.84 (95% CI 
[0.77, 0.88]), comparable to the results achieved by multi-layer neural networks with 
Youden and maximum accuracy.  
This procedure is very computationally costly; therefore, a robust framework was 
essential. Parallel processing was performed on a data analytics cluster of 11 servers 
with Xeon processors and 832GB fast RAM. We used the R software with some pack-
ages, including caret, pROC, e1071, randomForest, ggplot2, plyr, DMwR, AppliedPre-
dictiveModeling and doParallel [18].  
 
 
Fig. 2. 1000 Monte Carlo simulation for artificial neural networks. Where “SY” is single-layer 
NN with Youden cutting point, “ST” is single-layer NN with top-left cutting point, SM” is 
single-layer NN with maximum accuracy cutting point, “MY” is multi-layer NN with Youden 
cutting point, “MT” is multi-layer NN with top-left cutting point, and “MM” is multi-layer NN 
with maximum accuracy cutting point. 
In general, we detect that the proposed models have good predictive power and 
stability, based on an acceptable level of variation in their performance measures 
evaluated across extensive Monte Carlo experiments. However, the results indicate that 
the performance differences between the two types of neural networks with different 
methods for selecting the ROC cutting points are not significant regarding the 4 perfor-
mances.    
3 Cannabis use attributes’ predictive power 
After performing the Monte Carlo simulations, we further investigated the predictive 
models in order to better comprehend the predictive power of the cannabis-related 
attributes over ﬁrst-episode psychosis. Moreover, we investigated the association be-
tween cannabis-related attributes and ﬁrst-episode psychosis via statistical tests and at-
tribute-ranking techniques. 
10 
3.1 Student’s t-test 
In this subsection, we comprehend the predictive power of the cannabis-related attrib-
utes over ﬁrst-episode psychosis via statistical tests by re-ﬁtting our performing models 
but with the cannabis-related attributes, represented in Table 1, removed from the 
dataset. Then, we compared the performances with and without the cannabis-related 
attributes using Student’s t-test. We thereby demonstrated the predictive value of 
cannabis-related attributes with respect to ﬁrst-episode psychosis by showing that there 
is a statistically signiﬁcant difference between the performances of the predictive 
models built with and without the cannabis variables. 
Our analysis also showed that the accuracy decreased by 5% for single-layer neural 
networks and by 6% for the multi-neural networks, if the cannabis-related attributes 
were removed from the process of building the predictive models. Then, we compared 
the accuracies of the single-layer neural networks models built on the data sets with and 
without the cannabis-related attributes using one-tailed t-test. The p-value obtained for 
the t-test was 5.51 ×  10−195.  As for the multi-layer neural networks models built on 
the data sets with and without the cannabis use attributes, the p-value obtained for the 
one-tailed t-test was and  2 ×  10−16. This means that the predictive models with 
cannabis attributes have higher predictive accuracy than the models that were built 
without the cannabis attributes. In other words, the additional cannabis variables jointly 
account for predictive information over ﬁrst-episode psychosis. These results are con-
sistent with ﬁndings from [4].  
3.2 Ranking attributes’ importance with the ROC curve approach 
This subsection proposes the use of the ROC curves to determine the relevant variables 
affecting first-episode psychosis as introduced in [7]. We measure the individual im-
portance of every attributes in the dataset to discover the attributes that yield significant 
improvements in the model predictivity power. To do so, the ROC curve is considered 
on each attribute. Then, a series of cutoﬀs is applied to the data to predict the class. The 
sensitivity and speciﬁcity are calculated for each cutoﬀ, and the ROC curve is com-
puted. Finally, the area under the curve is used as a measure of variable importance. 
Table 3 shows the top 10 attributes ranked by the ROC curve approach.  















The results in Table 3 support prior evidence that cannabis attributes, such as the 
type of the cannabis used and the frequency of usage, have significant power in pre-
dicting first-episode psychosis. For example, the results in Table 3 support ﬁndings 
from [3] by associating the type of cannabis, especially high-potency cannabis, with the 
onset of psychosis. In addition, bindur.3 in Table 3, which represents the duration of 
cannabis use, is consistent with ﬁndings from [4].  
4 Conclusion and future work 
This paper proposes a novel machine learning approach to developing predictive mod-
els for the onset of first-episode psychosis using artificial neural networks. We explored 
two types of artificial neural networks, each of which was able to recognise patterns 
differentiating patients from controls at an acceptable level. We based our approach on 
a novel methodology for optimising and post-processing predictive models. We also 
proposed several sampling methods and several methods for choosing the optimal cut-
ting point on the ROC curve to improve the prediction models’ performances. The mod-
els were then further tested using Monte Carlo experiments, and they consistently 
yielded adequate predictive power and stability.  
The best-performing models were multi-layer neural networks, which achieved ac-
curacies as high as 88% in some cases and an average accuracy of 81% in Monte Carlo 
simulations with 1000 repetitions. The scored performances were above all perfor-
mances achieved in previous studies such as [3].  This paper extends on previous work 
as [3] by proposing a new machine learning framework based on a novel methodology 
in which models are post-processed based on optimized cut-off point selection on the 
ROC curve and evaluated with the recent method of k-fold cross testing which we adapt 
after [8]. Moreover, in this new framework, we developed optimized models with other 
powerful techniques such as artificial neural networks not addressed in [3].  Also, the 
predictive power of cannabis-use attributes was tested via statistical tests and ranking 
methods to demonstrate statistically that their presence in the dataset enhances the pre-
diction performance of the neural network models. The proposed approach proves the 
high potential applicability of machine learning and, particularly, artificial neural net-
works in psychiatry and enables researchers and doctors to predict and evaluate risks 
for first-episode psychosis. 
One possible direction for future work is to further investigate how this prediction 
performance variation evolves by limiting the uncertainty in the data, represented by 
the high proportion of missing values. The second possible work direction is redefining 
the predictive modelling approach by considering more high-dimensionality data, such 
as genotype data. A third future work direction, which we are currently investigating, 
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